Director Duncan Buell of Precision Optics Corporation, Inc. reported the acquisition of 30,000 stock options on November 18, 2026, in a filing submitted to the SEC on November 20, 2026.
Key Highlights
- Reporting person: Duncan Buell, identified as a Director of Precision Optics Corporation, Inc. (NASDAQ:POCI).
- Options granted: 30,000 stock options (rights to buy Common Stock) acquired on November 18, 2026, with a transaction code of A (acquired).
- Exercise price: $4.18 per share, with a price of derivative security listed as $0.
- Expiration date: November 18, 2036, giving the options a ten-year term from the grant date.
- Vesting schedule: Four equal installments on December 30, 2026, March 30, 2027, June 29, 2027, and September 29, 2027, subject to continuous employment.
- Equity plan: Options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan.
- Resulting ownership: Buell directly holds 30,000 derivative securities following this transaction.
Buell Option Grant Details and Vesting Terms at Precision Optics
According to the filing, Precision Optics Corporation, Inc., a company incorporated in Massachusetts and headquartered at 550 King Street, Littleton, Massachusetts, granted Director Duncan Buell stock options covering 30,000 shares of Common Stock. The options carry an exercise price of $4.18 per share and were granted on November 18, 2026, under the issuer's 2022 Equity Incentive Plan. The filing was signed by Joseph N. Forkey as attorney-in-fact on November 20, 2026.
As described in the filing's explanation of responses, the 30,000 options vest in four equal installments: December 30, 2026, March 30, 2027, June 29, 2027, and September 29, 2027. Each installment is "subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date." The options expire on November 18, 2036. Prior to this transaction, the filing reflects no pre-existing derivative security holdings for Buell, so his total beneficial ownership of derivative securities following the reported transaction is listed as 30,000 options held directly. No non-derivative securities transactions were reported in Table I of this filing.
What Was Disclosed
The filing reports that Director Duncan Buell received a grant of 30,000 stock options in Precision Optics Corporation, Inc. at an exercise price of $4.18, vesting in four equal installments through September 2027, under the company's 2022 Equity Incentive Plan.




Please wait processing your request...